307 filings
ARS
2023 FY
APRE
Aprea Therapeutics Inc
25 Apr 24
Annual report to shareholders
7:30am
DEFA14A
APRE
Aprea Therapeutics Inc
25 Apr 24
Additional proxy soliciting materials
7:15am
DEF 14A
APRE
Aprea Therapeutics Inc
Definitive proxy
25 Apr 24
7:00am
8-K
APRE
Aprea Therapeutics Inc
10 Apr 24
IND for APR-1051 has been cleared; details on planned Phase 1 first in human trial (ACESOT-1051) presented
4:15pm
S-3
APRE
Aprea Therapeutics Inc
Shelf registration
3 Apr 24
4:06pm
4
5iql3ahahrq 5rr5
28 Mar 24
Aprea Therapeutics / John P. Hamill ownership change
5:59pm
4
84n2t4fomvu0k4
28 Mar 24
Aprea Therapeutics / Oren Gilad ownership change
5:57pm
8-K
b25i83o jln7ae
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
4
f3ifsgh0l2p
14 Mar 24
Aprea Therapeutics / John P. Hamill ownership change
8:54pm
4
ahkc0qvrzqje
14 Mar 24
Aprea Therapeutics / Bernd R. Seizinger ownership change
8:53pm
4
ea0fswbb
14 Mar 24
Aprea Therapeutics / JOHN B HENNEMAN III ownership change
8:52pm
4
pqjl bw72nbif1qyujt
14 Mar 24
Aprea Therapeutics / Oren Gilad ownership change
8:51pm
8-K
860al2khay28gpf7
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
SC 13G
a5fbw yioph3peia0
14 Feb 24
Aprea Therapeutics / Sio Capital Management ownership change
8:00am
424B3
3lebob6gu
9 Feb 24
Prospectus supplement
12:00am
SC 13G/A
51wac5loaqwe
7 Feb 24
Aprea Therapeutics / HIRSCHMAN ORIN ownership change
6:55pm
8-K
rxvh6s8ces 6orvv7
6 Feb 24
Other Events
5:01pm
EFFECT
hhb3glm n2u
5 Feb 24
Notice of effectiveness
12:15am
424B3
5518zj7
5 Feb 24
Prospectus supplement
12:00am